comparemela.com
Home
Live Updates
K Securities And Exchange Commission - Breaking News
Pages:
Latest Breaking News On - K securities and exchange commission - Page 1 : comparemela.com
Infigratinib Receives Breakthrough Therapy Designation in China for Gastric Cancer
China’s National Medical Products Administration has granted a breakthrough therapy designation to infigratinib for the treatment of patients with gastric cancer.
United states
Yizhe wang
Bridgebio pharma
Helsinn birex pharmaceuticals
United states securities and exchange commission
K securities and exchange commission
China national medical products administration
National medical products administration
Helsinn healthcare
States securities and exchange commission
Securities and exchange
Gastrointestinal cancer
Global oncology
Chinas national medical products administration
Gastric cancer
vimarsana © 2020. All Rights Reserved.